Myrrh / Bol

Myrrh resin — harvested from Commiphora trees in Somalia, Yemen, and Oman — is one of the world's oldest recorded medicines, documented in ancient Egyptian papyri and Ayurvedic texts for cancer-like conditions. Modern pharmacology has validated this ancient use: furanodiene, curzerene, and lindestrene — sesquiterpenes in myrrh — induce apoptosis in MCF-7 breast cancer, prostate cancer, and ovarian cancer cells. Furanodiene specifically inhibits NF-κB and promotes TRAIL-induced apoptosis — the same pathway targeted by promising cancer immunotherapy drugs. Myrrh also inhibits 5-alpha reductase (relevant to prostate cancer), reduces cancer-related inflammation via COX-2 inhibition, and shows potent activity against drug-resistant cancer cell lines. The furanodiene content of myrrh is unique — not found in other common resins — making it pharmacologically distinct from frankincense despite both being oleoresins.